TY - JOUR T1 - First-line treatment options in metastatic castration-sensitive prostate cancer: A systematic review and network meta-analysis. JO - Journal of Clinical Oncology PY - 2022/02/20 AU - Riaz IB AU - Naqvi SAA AU - Ikram W AU - Siddiqi R AU - Asghar N AU - Khakwani KZR AU - Khalid A AU - Hussain SA AU - Singh P AU - Bryce AH ED - DO - DOI: 10.1200/jco.2022.40.6_suppl.132 PB - American Society of Clinical Oncology (ASCO) VL - 40 IS - 6_suppl SP - 132 EP - 132 Y2 - 2025/05/01 ER -